AZD 2066

Overview

AZD-2066 is a selective, orally active and blood-brain barrier-permeating mGluR5 antagonist . AZD 2066 activates the BDNF/trkB signaling pathway. AZD 2066 can be used in the research of neuropathic pain, major depressive disorder and gastroesophageal reflux disease.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > mGluR | Products > Signaling Pathways > Calcium Channel | Products > Signaling Pathways > Trk Receptor

Product Information

• Catalog No.: HY-110255
• CAS No.: 934282-55-0
• Molecular Formula: C19H16ClN5O2
• Molecular Weight: 381.82
• Purity: 99.8%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source